arrow
S

Soyoung Kim

innovation center for industrial mathematics
H指数:24
被引数:1,916

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Corrigendum to “Methyl jasmonate-induced hydroxycinnamoyl putrescine production in Lycium chinense cell suspension cultures” [Ind. Crops Prod. 250 (2026) 124046]

更正:“茉莉酸甲酯诱导中国枸杞细胞悬浮培养中羟基肉桂酰腐胺的产生” [Ind. Crops Prod. 250 (2026) 124046]

2026-08-140
OAAI
Optimizing Reduced-Intensity Conditioning for Older Patients with AML and MDS: A Large-Scale Analysis from the CIBMTR

优化老年AML和MDS患者减低强度预处理方案:来自CIBMTR的大规模分析

Blood
IF23.1
2026-01-010
PRE
New Comorbidity Index Associated with Survival After Chimeric Antigen Receptor T Cell Therapy for Large B-Cell Lymphoma

新型合并症指数与大型B细胞淋巴瘤嵌合抗原受体T细胞治疗后生存期的关联

2025-08-180
OAAI
Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysis

Brexucabtagene autoleucel治疗复发或难治性套细胞淋巴瘤的实效结果:一项CIBMTR分析

2025-07-280
OAAI
Elicitor-mediated enhancement of rosmarinic acid biosynthesis in cell suspension cultures of Lavandula angustifolia and in vitro biological activities of cell extracts

茉莉酸介导的迷迭香酸生物合成在薰衣草(Lavandula angustifolia)细胞悬浮培养物中的增强作用及细胞提取物在体外的生物活性

2025-07-010
OAAI
Real-World (RW) Outcomes for Brexucabtagene Autoleucel (Brexu-Cel) Treatment in Patients (Pts) with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-ALL) By High-Risk Features and Prior Treatments: Updated Evidence from the CIBMTR® Registry

真实世界(RW)结局:Brexucabtagene autoleucel(Brexu-Cel)治疗具有高风险特征及既往治疗史患者的复发或难治性B细胞急性淋巴细胞白血病(R/R B-ALL)结局;来自CIBMTR®登记数据的更新证据

BLOOD
IF23.1
2024-11-051
PRE
Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study
2024-08-142
OAAI
Incidence and Impact of Fungal Infections in PostTransplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis and Haploidentical Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis

移植后基于环磷酰胺的移植物抗宿主病预防和单倍体相合造血细胞移植中真菌感染的发生率和影响: 国际血液和骨髓移植研究中心分析

2024-01-015
PRE
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis
2023-02-0920
OAAI
The incidence and impact of clostridioides difficile infection on transplant outcomes in acute leukemia and MDS after allogeneic hematopoietic cell transplant—a CIBMTR study

难辨梭菌感染在急性白血病和MDS患者异基因造血细胞移植后的发生率及对移植结局的影响——CIBMTR研究

2022-12-210
PRE
Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities
2022-11-2214
OA
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis
2022-04-2115
OAAI
Comparison of hematopoietic cell transplant conditioning regimens for hemophagocytic lymphohistiocytosis disorders
2022-03-0120
OAAI
Allogeneic transplant and CAR-T therapy after autologous transplant failure in DLBCL: a noncomparative cohort analysis
2022-01-1827
OAAI